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Antigen processing and presentation by glomerular visceral epithelium
in vitro. Although macrophages are considered the prototype of antigen
presenting cells (APC), recent studies have emphasized the potential
role of several parenchymal and mesenchymal cells in this process. We
have studied the capacity of cultured glomerular visceral epithelial cells
(GEC) to act as effective APC and compared this capacity with that
demonstrated by peritoneal macrophages. Affinity-purified and in vitro
propagated rat GEC were exposed to hen egg lysozyme, keyhole limpet
hemocyanin, and cationic ferritin. As effector cells, we used antigen-
specific T cell hybridomas; the level of antigen presentation was
assessed by determining the level of interleukin 2 (IL-2) present in
tissue culture supernatants. Cytokine-treated GEC were capable of
processing and presenting all antigens in a dose-dependent manner.
Crucial for antigen presentation were intracellular processing of antigen
and the presence of Ia on the cell surface. Our findings indicate that
GEC can act as effective APC, and further suggest that this capacity
may be relevant to cell-mediated immune injury at the level of the
glomerular capillaries in vivo.
Mechanisms of immune-mediated glomerular injury have
been the subject of intense scientific investigation over the last
twenty years. Glomerular injury in most forms of disease has
been thought of as being dependent on antibody binding to
various glomerular components and mediated by complement
and/or neutrophils [1—10]. On the other hand, the pathogenesis
of glomerular diseases such as minimal change disease and
idiopathic diffuse crescentic glomerulonephritis without im-
mune deposits remains largely unexplored. Although there is no
structural evidence of antibody deposition within the compo-
nents of the glomerular capillary wall in either of these condi-
tions, there is sufficient indirect evidence to implicate immuno-
logical phenomena in the development of these two lesions [11].
Neither of these glomerulopathies is well modeled in experi-
mental animals, and hence the notion that they result from
cell-mediated immune injury remains, for the most part, spec-
ulative. It has been noted in patients and experimental animals
with crescentic glomerulonephritis that a significant proportion
of the inflammatory cells that accumulate in Bowman's space
have the phenotypic characteristics of macrophages [12—151,
and clear epithelioid cells and occasional giant cells can also be
identified. This pattern of immune injury can be viewed as a
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granulomatous reaction centered around the glomerular tuft. It
has been hypothesized that such a process could conceivably be
the result of a delayed type hypersensitivity reaction that takes
place within the space surrounded and enclosed by the glomer-
ular epithelium. Experiments that would more directly prove or
deny such assumptions have not been performed, and, more
specifically, the ability of glomerular visceral epithelial cells
(GEC) to act as APC or as accessory cells to an immune-
mediated attack has not been examined to date.
The glomerular epithelial cells are uniquely positioned within
the filtration pathway and are normally exposed in vivo to a
variety of exogenous peptides and proteins and endogenous
cytokines. Although normally operating size- and charge-selec-
tive barriers may limit the type of macromolecules that gain
access to the urinary space, the microenvironment of the GEC
is likely to be altered significantly in proteinuric conditions and
during antibody-initiated inflammatory processes to allow the
epithelium to become exposed to additional soluble mediators
and cellular elements of the blood. All these conditions are
potentially very critical for antigen presentation, a process that
could result in the initiation or amplification of a lesion by a
cell-mediated immune reaction.
We have studied the ability of in vitro propagated GEC to
process and present diverse antigens. Our studies indicate that
these epithelial cells have the capacity to upregulate critical
MHC antigens upon exposure to cytokines and to process and
present complex proteins to antigen-specific T cell hybridomas.
Methods
Reagents
Antigens of varying molecular sizes were utilized for these
studies. Keyhole limpet hemocyanin (KLH) was obtained from
Calbiochem (La Jolla, California, USA); this antigen has a
molecular weight of 3,500,000 to 7,000,000 daltons and an
isoelectric point between 5.0 and 6.0. Ferritin (Fe) was obtained
from Miles (Naperville, Illinois, USA), and cationized as pre-
viously described [161; this molecule is an oligomer composed
of 24 polypeptide chains each with a molecular weight of 18,000
to 19,000, yielding a macromolecule of approximately 500,000
daltons [17]. The native molecule is highly anionic with an
isoelectric point of 4.2; it does not filter in significant amounts
into the capillary wall or beyond it under normal conditions [16,
181. The chemically modified cationic molecule (CFe) readily
filters and reaches the GEC [16]; the CFe preparation used in
the current experiments has an isoelectric point ranging from
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7.5 to 9.5. CFe has been used extensively as an ultrastructural
tracer and in models of immune-mediated glomerular injury.
Hen egg white lysozyme (HEL) was purchased from Sigma
Chemical Co. (St. Louis, Missouri); it is a relatively small
(molecular wt 14,000 daltons), positively charged protein (p1 >
10) which has been used extensively in studies of antigen
presentation by murine macrophages [19—21]. The molecule
filters freely through the normal glomerular capillary wall [221
and is taken up avidly by the proximal tubule.
Tissue culture supplies were purchased from Gibco (Grand
Island, New York, USA) unless otherwise stated.
Animals
Lewis rats of either sex, weighing 50 to 60 g, and females,
weighing 125 to 150 g, were obtained from Charles River
Breeding Laboratories (Wilmington, Massachusetts, USA).
Animals were allowed free access to food and water, and were
maintained and handled in accordance with the guidelines of the
Committee on Animals of Harvard Medical School and those
prepared by the Committee on Care and Use of Laboratory
Animals of the Institute of Laboratory Animal Resources,
National Research Council.
Monoclonal antibodies
Monoclonal antibodies (mAb) directed against glomerular
visceral epithelial cells and subclass-matched antibodies that do
not recognize GEC antigens were produced as previously
described [23]. MRC OX-18 and OX-6 hybridomas, directed
against class I and II antigens of the rat, respectively, were
provided by Dr. Alan Williams, University of Oxford, England.
mAb were produced in supernatant form or as an immunoglob-
ulin (Ig) fraction obtained from ascites fluid as previously
reported [24].
In vitro propagation of GEC
Glomeruli were sieve isolated from Lewis rats (50 to 60 g) and
digested for 45 minutes in Hank's balanced salt solution (HBSS)
containing 10 mrvi HEPES, 0.4% collagenase type II (CLS II,
Worthington Biochemicals, Freehold, New Jersey, USA), 0.2%
soybean trypsin inhibitor (Gibco), 2 M Leupeptin (Boehringer
Mannheim Biochemicals, Indianapolis, Indiana, USA), and 5
g/ml deoxyribonuclease (Sigma), at pH 7.5. The suspension
was then forced through a 38 sm sieve and the cells incubated
with a mAb specific for GEC. The cells were then washed and
purified by positive panning using polystyrene dishes coated
with affinity-purified rabbit anti-mouse IgG as previously de-
scribed [25]. The purified GEC were resuspended in cell culture
medium, cultured and subcultured on thick collagen type I
matrices as described by Harper et al [261. Cells were routinely
utilized between passage 10 and 25. Since such thick collagen
gels have a high adsorptive capacity that interferes with various
assays, GEC were resuspended from such matrices 24 hours
prior to all immunohistochemical or antigen presentation assays
and re-plated onto culture surfaces coated with a thin layer of
collagen type I.
Production of T cell hybridomas
T cell hybridomas were generated following a modification of
the technique reported by Happ and Heber-Katz [27]. In brief,
125 to 150 g Lewis rats were immunized at the base of the tail
with 1 mg of antigen in CFA. Ten to twenty days later the
draining lymph nodes were removed. The lymphocytes were
depleted of B cells by panning [28], and this T cell enriched
population was co-cultured with normal Lewis rat peritoneal
macrophages for four days in the presence of 10 to 40 sg/ml of
the antigen. The viable cells were fused with BW5 147 thymoma
cells at a 1: 1 ratio in 50% polyethylene glycol 1500. Hybrids
were cloned by limiting dilution. In the current studies we have
used hybridomas specific for KLH (TH 2/2), ferritin (TH 29/28),
and HEL (TH 32/21). These hybridomas are antigen specific
and do not respond when co-cultured with APC exposed to
other proteins.
Hybrids were tested for antigen specificity by their produc-
tion and release of IL-2 in the presence of APC and 10 to 100
g/ml immunogen. For this purpose, T cell hybridomas were
plated at 1 X 104/well in 96-well, flat-bottomed tissue culture
plates with or without antigen. To each well, 1 x iO normal
Lewis rat peritoneal macrophages were added. Forty-eight
hours later, an aliquot of supernatant was removed and frozen
at —70°C. The production of IL-2 was estimated by a bioassay
using an IL-2 dependent cell line, CTLL, as described by
Leyva-Cobian and Unanue [29].
Antigen presentation by GEC and macrophages
GEC were propagated on thick collagen matrices and ex-
posed to recombinant rat IFN-y (Amgen Biologicals, Thousand
Oaks, California, USA) at various concentrations (0 to 100
U/ml) for three to four days. These cells were then resuspended
from the collagen matrix with HBSS + HEPES containing 0.2%
CLS II and treated briefly with trypsin-versene to increase their
passage efficiency. The GEC were resuspended in TH medium
(RPMI 1640 containing 10% fetal calf serum, 10 mM HEPES, 2
mM L-glutamine, 1 m sodium pyruvate, 0.05 mr'vi 2-mercapto-
ethanol, and 0.1 m Eagle non-essential amino acids) and
plated at approximately 15,000 cells/well into 96-well tissue
culture plates that had been pre-coated with a thin layer of type
I collagen. Cells were then exposed to antigen (KLH or HEL)
and 100 U/ml of recombinant rat IFN-y for 18 to 24 hours.
Immediately prior to fixation and co-culturing with hybridomas,
GEC were re-fed and cultured for two hours in TH medium with
antigen but in the absence of the cytokine. Since CFe precipi-
tates in the presence of serum components, continuous over-
night exposure to this antigen was omitted. Instead, 24 hours
prior to the antigen presentation assay, GEC were incubated
without FCS for 30 minutes at 37°C in DMEM (M.A. Bioprod-
ucts, Walkersville, Maryland, USA) containing 10 mt HEPES,
L-glutamine, and various concentrations of CFe. The superna-
tant with the antigen was then removed and the cells re-fed with
TH medium and IFN-y for the overnight incubation. The cells
were then re-exposed to CFe without FCS or the cytokine for
two hours just prior to fixation.
The antigen presentation assays for GEC were always run in
parallel with macrophages, and the results obtained with both
cell types were compared. Normal Lewis rat peritoneal macro-
phages were isolated, resuspended in RPMI 1640 containing 5%
FCS, 2 m'vi L-glutamine and 10 mi HEPES and placed at 1 X
105/well in 96-well tissue culture plates [29]. After two hours at
37°C, the non-attached cells were removed. Macrophages were
then exposed to the appropriate antigen contained in TH
medium for two hours at 37°C. As described above for GEC,
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macrophages were incubated with CFe in serum-free medium
for two hours.
It should be noted that the assay systems used with GEC and
macrophages are slightly different. This is due to preliminary
studies which revealed that optimal APC activity of GEC is
obtained after 18 to 24 hours of antigen exposure while macro-
phage ability is superior after two hours. Similarly, for each cell
type, the density of APC was also varied to obtain optimal
activity (results not shown).
For the antigen presentation assay, wells containing GEC or
macrophages previously exposed to antigen were washed twice
with HBSS + HEPES and fixed for 15 to 20 minutes with 1%
paraformaldehyde [30]. We found the fixation step to be neces-
sary since preliminary studies suggested that GEC culture
supernatants contain a suppressor factor of IL-2-dependent
lymphocyte and CTLL replication, as described for other in
vitro systems [31—331. After fixation, the wells were washed
three times with RBSS + HEPES and incubated overnight at
37°C in TH medium 130, 34].
Wells containing fixed GEC or macrophages were washed an
additional three times with HBSS + HEPES, and the T cell
hybridomas were added at 1 x iO cells/well. Forty-eight hours
later, supernatants were removed and tested for the presence of
IL-2 as described above. Each experiment was performed in 12
replicate wells unless otherwise specified. A titration of the
IL-2-containing medium was performed with the CTLL cells to
ensure that any given sample was assayed within the linear
component of the dose-response curve under the conditions
described above [20].
To rule out self-presentation of antigen by the T cell hybrid-
omas, these cells were cultured at 1 x l0 cells/well in the
presence of antigen but without added APC. To confirm that the
antigens under study required intracellular processing before
proper presentation to the T cell hybridoma, macrophages were
fixed prior to exposure to antigen [30]. The supernatants were
tested for IL-2 activity as described above.
Radioimmunoassay
MRC OX-18 and OX-6, IgG1 mAbs, were used for the
detection of cell surface MHC class I and class II antigens. An
isotype matched, non-GEC reactive mAb served as a negative
control. GEC were treated with increasing concentrations of
recombinant rat IFN-y for four to five days and then passaged
into wells of a 24-well plate which had been precoated with a
thin layer of type I collagen. Following an additional 24 hour
exposure to IFN-y, the wells were washed twice with HBSS
containing 10 mM HEPES at pH 7.5 and fixed with 1% para-
formaldehyde in PBS for five minutes. The aldehyde-reactive
sites were blocked with serum containing medium and the cells
sequentially incubated at room temperature for one hour with
the mAb (Ig fraction of ascites containing 30 g/ml protein) and
0.5 to 1 x 106 cpm/well of 1251 sheep anti-mouse Ig (NEN,
Boston, Massachusetts, USA). The cells were washed, solubi-
lized in 1% SDS in distilled water and the bound antibody
quantitated in a gamma counter. The results of these assays
were expressed as the ratio of radioactivity and the protein
content as determined by a modified Lowry technique [35],
since GEC had the tendency to clump upon resuspension and
an absolutely even distribution of cells within all wells was not
assured. Peritoneal macrophages from normal Lewis rats were
processed in parallel, as described above, following a two hour
adherence to 96-well tissue culture plates.
Immunohistochemical techniques
Localization of MHC class I and class II antigens on in vitro
propagated GEC was performed by immunohistochemical
means on cells plated onto thin collagen matrices as described
above. The cells were fixed in paraformaldehyde for five
minutes as described above, washed, and processed immedi-
ately or permeabilized for 10 minutes in acetone/methanol (1: 1,
vol/vol). The cells were then sequentially incubated with a
mAb, affinity-purified rabbit anti-mouse Ig, sheep anti-rabbit 1g.
and peroxidase-anti-peroxidase complex as previously reported
by us [25]. In all tests, isotype-matched, non-GEC binding
mAbs were used as negative controls. The binding patterns
exhibited by mAbs in the normal kidney were revealed on
frozen sections by indirect immunofluorescence microscopy
using supernatants as previously described [36].
The mAb used for the affinity purification of GEC was further
characterized in its binding specificity at the ultrastructural
level on unfixed, sieve isolated glomeruli as previously reported
[36].
Statistical analysis
Differences between experimental groups were analyzed for
statistical significance by unpaired t-test or one-way ANOVA
when the number of groups exceeded two. Multiple pairwise
comparisons by the procedures of Bonferroni, Tukey, and
Scheffe were performed when the ANOVA showed a statistical
significance with a P value < 0.05. SAS-PC version 6.03 was
utilized for these analyses (SAS Institute Inc., Cary, North
Carolina, USA).
Results
Isolation, purification, and culture of GEC
GEC were affinity-purified from collagenase digested glomer-
uli using K35/3 1, a mAb that recognizes a determinant present
on their cell surface. As visualized by indirect immunofluores-
cence microscopy (Fig. 1), the glomerular capillary wall shows
intense binding of this antibody while the parietal epithelium
underlying Bowman's capsule is negative. At the ultrastructural
level, we could demonstrate that this mAb specifically reacted
with an epitope present along the surface of the main body and
all podocytic extensions of the visceral epithelium but not on
the surface of the endothelium or the matrix of the glomerular
basement membrane (Fig. 2). The glomerular parietal epithe-
hum covering Bowman's capsule was consistently negative (not
shown).
GEC were affinity-purified with this mAb and propagated in
vitro. Phase microscopy and ultrastructural analysis revealed
epithelioid cells that exhibit all the structural characteristics
reported by Harper et al for these cells in culture [26].
Antigen presentation by GEC
When in vitro propagated GEC were cultured for four to five
days in the presence of 100 U/ml IFN-y, they were capable of
processing and presenting complex antigens to T cell hybrid-
omas. Dose response curves for KLH, HEL, and CFe obtained
with GEC and peritoneal macrophages are summarized in
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measured, the results expressed as counts per minute per g of
protein, and normalized with a non-binding isotype matched
mAb. As a comparison, an RIA was performed on normal
macrophages isolated from rat peritoneum. The expression of
class I and II molecules (321 and 132 cpm/sg of protein,
respectively) was, as expected, much higher on these cells than
on GEC treated in vitro with IFN-y.
Class II molecules were also demonstrated by immunohisto-
chemical techniques on the majority of the GEC following
treatment for four days with 100 U/nil rat IFN-y (not illustrat-
ed).
Discussion
Fig. 1. Distribution of antigen recognized by mAb K35131. There is a
diffuse distribution of mouse Ig along the glomerular capillary wall. The
parietal epithelium and endothelium of peritubular capillaries are neg-
ative. (Indirect immunofluorescence microscopy on normal rat renal
cortex, magnification: x 550).
Figure 3. Under the experimental conditions described above,
the response curve for GEC consistently appears shifted to the
right by two orders of magnitude when compared to that
obtained for macrophages.
Hybridomas exposed to high concentrations of the respective
antigen but cultured in the absence of APC were not able to
increase IL-2 production significantly, as shown by our results
depicted in Table 1. These findings clearly suggest that hybrid-
omas TH 2/2, TH 29/28, and TH 32/21 do not possess the
capacity for antigen self-presentation and that our results with
GEC are due to effective antigen presenting capacity by these
cells. Furthermore, intracellular processing was critical for
effective antigen presentation by macrophages since fixation of
these cells prior to antigen exposure completely abolished IL-2
production by the hybridomas (Table 1).
The need for upregulation of MHC molecules on GECfor
effective antigen presentation
As is true for other cells that function effectively as APC,
GEC also need to express products of the genes of the MHC on
their cell surface. Table 2 summarizes data of experiments
performed with passaged GEC exposed to IFN-y and similar
cultures grown in the absence of this cytokine. As shown, only
cultures exposed to the cytokine were capable of acting as
APC. The RIA to detect MHC molecules on GEC exposed to
increasing concentrations of IFN-y shows the appearance of
measurable class II molecules on cells treated with 100 U/ml of
the cytokine, while class I antigens are present constitutively
and upregulated after treatment with only 10 U/mi (Table 3).
Since the GEC had a tendency to clump after resuspension
following treatment with collagenase and trypsin, equal cell
density from well to well could not be assured. Therefore, the
amount of protein in the wells utilized for the RIA was
The studies presented here support the notion that GEC
propagated in vitro are capable of processing and presenting
complex macromolecules to T cell hybridomas. This capacity is
critically dependent on the induction of MHC Class II glyco-
proteins on the epithelial cells by prior exposure to IFN-y. Our
in vitro studies also show that the T cell hybridomas utilized in
these experiments require a competent APC since they were
unable to self-present the exogenous antigens. Furthermore,
fixation of the APC prior to exposure to any of the antigens used
in our experiments effectively abolishes antigen presentation, a
finding that suggests that an intracellular processing step is
required before interaction with these hybridomas.
Our results indicate that GEC could perform as effective APC
for soluble antigens, including HEL, CFe and KLH, three
proteins ranging in molecular weight from 14,000 to 7,000,000
daltons. However, these cells were poor at presenting anionic,
native ferritin (data not presented). That the molecular charge
may be a key determinant in cellular uptake and lysosomal
degradation has been demonstrated previously for various cell
types [37—411. Studies that more formally address the effect of
molecular charge on antigen presentation by these epithelial
cells over a broader range of molecular sizes are currently in
progress in our laboratory.
As shown by these in vitro studies, the presence of Ia on the
surface of GEC is critical for antigen presentation, as reported
previously for numerous other systems [reviewed by Unanue
and Allen [421. While class I MHC molecules appear to be
expressed constitutively at low levels on the surface of in vitro
propagated GEC, Ia is detectable only after IFN-y treatment.
This situation is not unprecedented for cultured cells since
human umbilical vein endothelial cells respond similarly under
comparable conditions [43, 441. In the intact animal, several
immune stimuli have been shown to increase the expression of
Ia by the epithelium of renal proximal tubule in vivo [45—48]. In
many of these instances, glomerular cells exhibited an in-
creased amount of class I antigen but little class II. The reason
for this variability in class II expression in vivo among different
epithelia within the renal cortex has not been determined,
although several hypotheses have been proposed [45, 48].
Nevertheless, most, if not all, cell types cultured in vitro have
been induced to express class II molecules by exposure to
appropriate cytokines. This may be related to the state of
dedifferentiation attained by highly specialized cells under in
vitro conditions [49—51], to the higher concentrations of the
cytokine reached in culture, or to the difference in sensitivity of
the assays used for cultured cells (RIA, flow cytometry) and
organ sections (immunohistochemistry). A recent study con-
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Fig. 2. Ultrastructural localization of the
binding of IgG2 mAb K35131 and K23117 to
the glomerular capillary wall, a. The antigen
recognized by K3513 1 is present along the
surface of the glomerular visceral epithelium.
The glomerular basement membrane and
endothelium are negative. b. K23/17 is a mAb
directed against an epitope present exclusively
on peritubular capillaries and used in these
experiments as a negative control. Note that
the entire glomerular capillary wall is non-
reactive. Ep = glomerular visceral epithelium,
US = urinary space, CL = capillary lumen.
(x 21,500).
ducted with cultured mesangial cells has also shown that these
contractile cells can readily be induced to express Ia upon
treatment with IFN-y [52] while immunohistochemical studies
in intact animals have been consistently negative.
The amount of class II antigen expressed by GEC in vitro is
significantly lower than that seen on the surface of normal
macrophages. However, since passaged GEC are capable of
acting as APC only after exposure to IFN-y, this small level of
class II antigen or of some other co-stimulatory molecule as
described on B cells [34] appears to be of critical importance for
antigen presentation. This further suggests that possibly small
amounts of class II antigens on cells in vivo may be relevant for
this function, and it is likely that such minor quantities are
beyond the sensitivity of the tests routinely utilized on tissue
sections.
Epithelia from various tissues have been propagated in vitro
and examined for APC activity. A recent study performed with
transformed lines of murine proximal tubule epithelium demon-
strated the capacity of such cells to express Ia after stimulation
with IFN-y and to present HEL to murine T cell hybridomas
[53]. However, the presence of Ia on the surface of epithelial
cells is not sufficient in itself to confer antigen presenting
capabilities. For example, although IFN-y induces Ia molecules
on the surface of murine thyroid follicular epithelium in an
amount comparable to spleen cells, these cells fail to present
insulin, ABA or thyroglobulin to T cells, T cell lines or
hybridomas [54]. Ia positive keratinocytes can present peptides
but not intact proteins to T cell hybridomas [551, suggesting that
they lack the required intracellular processing mechanisms.
While some epithelia can augment an immune attack, they can
also suppress T cell responses, as has been reported for
keratinocytes [55] and pancreatic beta cells [56]. Therefore, the
ability of GEC to process and present complex antigen to T cell
hybridomas may illustrate a unique capacity not expressed by
many types of epithelia.
Our in vitro findings may be of critical relevance for glomer.
ular disease processes suspected to be brought about by cell-
mediated immune mechanisms in vivo. The structural expres-
sion of such processes most characteristically involves the
development of crescents, a form of inflammation considered
by most investigators akin to a granulomatous reaction centered
around the glomerular capillary tuft. Although endothelial cells
[44, 57] and elements within the mesangium [58, 59] could be
important in the generation of such a reaction, the location of
the mononuclear inflammatory cells, including lymphocytes,
macrophages, epithelioid cells, and giant cells within Bowman's
space suggests that the epithelium may be a key player in this
process. To this effect, a number of previous studies have
convincingly demonstrated active in vivo endocytic uptake by
rat GEC of various macromolecular tracers, including dextrans
[601, native ferritin [61], CFe [18], and protamine-heparin
complexes [62, 63]. While immune complexes deposited within
the glomerular capillary wall are also liable to be removed by
the GEC, the rate of immune complex clearance is not precisely
known but is felt to be rather sluggish [64]. However, as is the
case for the B lymphocyte, the process of antigen removal from
the underlying basement membrane by GEC also seems to
occur with greater efficiency when an integral cell membrane
component is involved [65]. All these observations suggest that
the ability of GEC to endocytose macromolecules may be
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Fig. 3. Antigen presentation by GEC (•) and peritoneal macrophages
(A) to T cell hybridomas as determined by the proliferative response of
an IL-2 dependent cell line.
dependent to some extent on the molecular charge and, poten-
tially, other biophysical or chemical characteristics of the
antigen that determine the nature of the interaction with the cell
surface. Our studies further suggest that the epithelium of the
glomerulus may play an active role in cell-mediated immune
processes by functioning as an APC, presumably by expressing
antigenic epitopes in the context of upregulated Ia. Virtually no
information is available at present as to the accessory signals
necessary for such a function and to potential sources of such
Table 1. IL-2 production by T cell hybridomas in the absence of
added APC or co-cultured with pre-fixed or post-fixed macrophages
Post-fixed
Hybridoma Antigen No APC Pre-fixed APC APC
TH 2/2 KLH 32 2232 2,713 2523 32,136 261l
TH 29/28 CFe 27,968 35l4
TH 32/21 HEL 238 798 27,198 360&
Normal Lewis macrophages were allowed to adhere to microtiter
plates and then left alive or fixed with 1% paraformaldehyde prior to
exposure to antigen. T cell hybridoma were added to each well in media
alone or in media containing 1000 jig/mi antigen (final concentration)
with the exception of CFe. For this antigen, a 30-minute pulse exposure
was chosen since CFe precipitated in the presence of serum. Following
exposure to CFe, TH 29/28 was added to the wells with or without
macrophages. Supernatants were collected and analyzed for the pres-
ence of IL-2. Each test was performed in six replicate wells. Results are
expressed as the mean standard deviation. Values represent the
average 3H thymidine incorporation into CTLL cells exposed to super-
natants from APC and antigen minus the average of the background 3H
thymidine poration derived from similar and parallel experiments in
which the antigen was omitted.
a p < 0.05 when compared to values obtained without APC or with
pre-fixed APC (1-way ANOVA followed by relevant pairwise compar-
isons)
Table 2. Effect of IFN-y on antigen presentation by GEC to T cell
hybridomas
Dose of IFN-y
0 U/mI 100 U/mI
TH 2/2 KLH 103 356 16,379 6,450a
TH 29/28 CFe 396 749 18,360 3,639a
TH 32/21 HEL <0 24,074 11,660a
GEC were incubated in the presence or absence of 100 U/mI rat
gamma interferon for 4 to 5 days. During the last 24 hours they were
cultured with or without antigen. The GEC were fixed in paraformal-
dehyde, and T cell hybridomas were added to each well. After 48 hours,
the supernatant was collected and assayed for the presence of IL-2. The
results are the mean standard deviation of the difference between
cells incubated with and without antigen. Each test was performed in 12
replicate wells.
a P < 0.05 when compared to values obtained from wells not exposed
to the cytokine (Student's t-test)
Table 3. Radioimmunoassay for MHC Class I and Class II antigen
expression on GEC following IFN-y treatment
mAb
CPM/ jig protein; dose of IFN-y
Specificity 0 U/mI 10 U/mI 100 U/mI
OX 6 Class II 0 1 0 3 10 a
OX 18 Class I 54 11 100 iia 88 9
The results are expressed as the mean standard deviation of the
cpm/ jig protein. Each test was performed in triplicate and normalized
with a subclass-matched mAb that does not recognize antigens on the
GEC.
a p < 0.05 when compared to values obtained in cells exposed to 0
U/mI of the cytokine (I-way ANOVA followed by multiple pairwise
comparisons).
factors in vivo. However, recent animal experiments performed
by us in the rat, directly introducing a hapten into the renal
parenchyma via intraarterial perfusion of activated azobenzene-
arsonate, also suggest that cellular elements within the kidney
0.01 0.1 1
0.01 0.1 1 10 100 1000
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may directly participate in a cell-mediated granulomatous in-
flammation that involves all cortical elements, including the
glomeruli [661 (manuscript in preparation). Such studies indi-
cate that antigen presentation by intrinsic renal parenchymal
cells is very likely to occur in vivo and that the necessary
accessory signals are locally released in sufficient amounts to
sustain a classic delayed type hypersensitivity reaction.
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